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ABSTRACT
Aims: Patients with chronic kidney disease (CKD) are also susceptible to periodontitis. The causal 
link between periodontitis and CKD may be mediated via systemic inflammation/oxidative stress. 
Using structural equation modelling (SEM), this cross-sectional study aimed to explore the causal 
relationship between periodontal inflammation (PI) and renal function. 
Materials and Methods: Baseline data on 770 patients with stage 3-5 (pre-dialysis) CKD from and 
ongoing cohort study was used. Detailed, bio-clinical data on PI and renal function, as well as 
potential confounders and mediators of the relationship between the two, was collected. SEMs of 
increasing complexity were created to test the causal assumption that PI affects renal function and 
vice versa. 
Results: SEM confirmed the assumption that PI and renal function are causally linked, mediated 
by systemic oxidative stress. The magnitude of this effect was such that a 10% increase in PI 
resulted in a 3.0% decrease in renal function and a 10% decrease in renal function resulted in a 
25% increase in PI.
Conclusions: PI represents an occult source of oxidative stress in patients with CKD. Further 
clinical studies are needed to confirm whether periodontal therapy, as a non-pharmacological 
approach to reducing systemic inflammatory/oxidative stress burden, can improve outcomes in 
CKD.
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Clinical relevance
Scientific rationale for study: Periodontitis is associated with chronic kidney disease (CKD). This 
study aimed to explore the causal mechanisms due to which these associations might occur. 
Principal findings: Using structural equation modelling, this study confirmed the causal hypothesis 
that periodontitis and kidney function have a bi-directional relationship. This relationship is 
mediated via systemic oxidative stress. 
Practical implications: It is yet to be determined whether the resolution of periodontal 
inflammation, via periodontal therapy, can influence the progression of CKD and studies are 
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Introduction
Chronic kidney disease (CKD) affects 8-16% of the global population (Jha et al., 2013) and is 
strongly associated with premature mortality secondary to cardiovascular disease and progression 
to end-stage kidney disease. Prognostic factors associated with worse outcomes in CKD include 
severity of kidney disease (Go, Chertow, Fan, McCulloch, & Hsu, 2004), systemic inflammation 
and oxidative stress (Cachofeiro et al., 2008; Small, Coombes, Bennett, Johnson, & Gobe, 2012). 
Periodontitis is a common chronic inflammatory disease affecting the connective tissues 
surrounding teeth. Severe periodontitis affects over 7% of the world’s population (Kassebaum et 
al., 2017). Periodontal inflammation is associated with increased systemic inflammatory and 
oxidative stress (Allen, Matthews, Halloran, Griffiths, & Chapple, 2011; Tonetti & VanDyke, 
2013). 
The association between periodontitis and CKD has been highlighted (Craig, 2008; Franek et al., 
2006; Kshirsagar et al., 2005). CKD is associated with a two-fold increase in the prevalence of 
periodontitis (Deschamps-Lenhardt, Martin-Cabezas, Hannedouche, & Huck, 2018). Periodontitis 
has been associated with increased all-cause mortality in patients with CKD (Zhang, Jiang, Sun, & 
Chen, 2017). Periodontitis is also associated with worse outcomes in patients with cardiovascular 
disease (Dietrich, Sharma, Walter, Weston, & Beck, 2013) and diabetes (Sanz et al., 2018). 
Periodontitis treatment reduces plasma concentrations of pro-inflammatory mediators (D'Aiuto, 
Orlandi, & Gunsolley, 2013; D'Aiuto et al., 2004; Demmer et al., 2013; Freitas et al., 2012; Teeuw 
et al., 2014) and, in patients with diabetes, reduces glycated haemoglobin (HbA1C) by 0.27–
0.48% (Sanz et al., 2018). 
As inflammation and oxidative stress play a role in the pathobiology of periodontitis and CKD, 
these diseases may amplify adverse outcomes when occurring concomitantly (Deschamps-
Lenhardt et al., 2018). For example, periodontal inflammation could influence renal function 
through the dissemination of intact bacteria (Kshirsagar, Offenbacher, Moss, Barros, & Beck, 
2007) bacterial products or pro-inflammatory cytokines from inflamed, ulcerated periodontal 
tissues (Cekici, Kantarci, Hasturk, & Van Dyke, 2014; Taylor, Preshaw, & Lalla, 2013; Tonetti & 
VanDyke, 2013). CKD may affect periodontal inflammation via increases in systemic 
inflammatory and/or oxidative stress burden (Cachofeiro et al., 2008; Oberg et al., 2004; Small et 
al., 2012). It is also possible that associations between periodontal inflammation and renal function 
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Structural equation modelling (SEM) techniques elucidate complex biological relationships by 
integrating causal hypotheses in multiple, simultaneous regression models. This allows a variable 
to simultaneously be both an “exposure” in one path and an “outcome" in another. SEM can thus 
quantify the direct and indirect effect of one variable on another. 
In this study we utilised SEM to assess a well-characterised cohort of patients with CKD from an 
established cohort study. We aimed to assess the effect of periodontal inflammation on renal 
function and vice versa, and how these effects may be mediated. 
Materials and Methods
Secondary analysis was carried out using data derived from baseline assessments in a prospective 
cohort study, the Renal Impairment In Secondary Care (RIISC) study (Stringer et al., 2013). 
Briefly, between October-2010 and December-2015 the RIISC study recruited a cohort of patients 
with CKD who were at high risk of adverse outcomes. 
Participants had been under follow up in a secondary care renal clinic for at least 1-year prior to 
recruitment and fulfilled 2008 National Institute of Clinical Excellence CKD guidelines for 
referral to a specialist service for management of CKD. Inclusion criteria comprised either CKD 
stage 3 with an estimated glomerular filtration rate (eGFR) decline ≥5mls/min/year or 
≥10mls/min/5years; or CKD stage 4 or 5 (pre-dialysis); or a urine albumin creatinine ration 
(ACR)>70mg/mmol on three occasions. Patients undergoing renal replacement therapy (dialysis 
or kidney transplant) or receiving treatment with immunosuppressive medication were excluded. 
The study was approved by the South Birmingham Local Research Ethics committee 
(ref:17010/H1207/6) and University Hospitals Birmingham Research and Development 
department (ref:RRK3917). It was conducted following the principles of the Declaration of 
Helsinki with participants giving written informed consent. The study is registered on 
clinicaltrials.gov (ref:NCT01722383). STROBE (Strengthening the reporting of observational 
studies in epidemiology) guidance was used in the generation of this manuscript.
Renal assessments
The CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation, incorporating 
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a Roche Modular Analyser using a blank rated compensated Jaffe reaction. Albuminuria was 
assessed using urine ACR which was measured using the ADVIA 1800 Chemistry System (Bayer 
HealthCare).
Periodontal assessments
Participants underwent a full-mouth, detailed periodontal assessment, recording periodontal 
probing depths (PPD), gingival recession and clinical attachment loss at interproximal sites of all 
teeth present. Bleeding on probing (BOP) was recorded at each site (present/absent). The PPD and 
BOP data were used to calculate the periodontal inflamed surface area (PISA) (Nesse et al., 2008), 
which is an estimate of the area (in mm2) of the inflamed periodontal tissue. To aid description of 
this cohort, cases of periodontitis were defined using the Page and Eke 2007 classification (Page & 
Eke, 2007) and mean PPD, CAL and BOP were calculated. 
Assessment of inflammation and oxidative stress
C-reactive protein (CRP) was measured from serum samples using the Full Range CRP Kit (range 
from 0.2-400 mg/L) (The Binding Site Group Ltd, UK). The polyclonal serum free light chain 
(sFLC) concentration, a measure of systemic humoral response, was the summation of κ and λ 
sFLC concentrations obtained using the Dade-Behring Nephelometer II (BNII) Analyzer 
System(Siemens AG, Erlangen, Germany) and particle enhanced high-specificity homogenous 
immunoassays (Freelite: The Binding Site Group Ltd, UK). 
Systemic oxidative stress was evaluated by measurement of protein carbonyls (protein oxidation), 
and F2-α-isoprostanes (lipid peroxidation). Protein carbonyls were assessed by ELISA following 
the method of Carty et al., 2000. 8-isoprostane F2α levels were measured by EIA method 
according to manufacturer’s instructions (Cayman Chemicals, USA).
Demographic and other laboratory variables
Patient age in years, sex (male/female), ethnicity (White or non-white), smoking status 
(current/former/never), diabetes (yes/no), employment status (yes/no) and educational attainment 
were ascertained. Measurements of body height and weight were carried out to determine body-
mass index (BMI) and venous blood samples were taken to assess HbA1C and serum 
concentrations of calcium, phosphate and bicarbonate. Blood pressure (BP) was measured using 
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reported to be comparable to the mean daytime BP from 24-hour ambulatory BP monitoring 
(Brothwell, Dutton, Ferro, Stringer, & Cockwell, 2013). Hypertension, defined as use of 
antihypertensive medication or average systolic BP>=140mmHg or average diastolic 
BP>=90mmHg, was used in the analyses. Formation of advanced glycation endproducts (AGEs) is 
accelerated by increased systemic glucose levels (Yan, Ramasamy, & Schmidt, 2008). The 
deposition of AGEs in skin was measured using skin autofluorescence (AGE reader TM, 
Diagnoptics Technologies, The Netherlands).
Statistical analysis 
To test proposed causal assumptions, we specified SEMs based on causal diagrams (Figures 1&2). 
Causal diagrams take a structural approach to assessing the potential for confounding and 
mediation (Greenland, Pearl, & Robins, 1999; Heaton & Dietrich, 2012). SEMs were used to 
estimate the direct effect of all predictive variables on outcomes of interest. In addition to the base 
model (model 1, Figures 1&2), models of increasing complexity were considered. Model 2 (* in 
Figures 1&2) included HbA1C and BMI as additional causal determinants of systemic CRP and 
oxidative stress levels. Model 3 (** in Figures 1&2) captured the interplay between CRP and 
oxidative stress by adding a feedback loop between these. 
Latent variables for oxidative stress, diabetes and SES, were obtained following discussions with 
the authors as to the causal relationship between the latent variables and the observed variables 
that load onto them. The standardized direct effects were estimated using maximum likelihood 
with missing values to account for missing data. All analyses were carried out using Stata/IC 
version 15.1 (StataCorp LLC). Robust estimations of the standard errors were generated using 
STATA’s “vce (robust)” command with a 2-sided significance level of 0.05. The unstandardized 
indirect effects were calculated using the products of the path coefficients along the indirect path 
between exposure and outcome. Direct and indirect effects were presented, along with the 95% 
confidence interval. The in/direct effects are interpreted as the effect on the outcome for a 1-unit 
change in the exposure. Here, the “unit” is scaled to a percentage, hence the coefficients are 
interpreted as the percentage change in outcome for a 10% change in exposure. Details of model 
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Study Population. Between October 2010 and December 2015, 770 participants were recruited 
into the RIISC study at the centre where periodontal assessment was being done. 93.6% (n=721) 
of participants underwent a detailed periodontal examination.  Of these, 15% (108) were 
edentulous and were excluded from further analysis yielding a final sample size of 613. Of these, 
5% (n=30) were periodontally healthy, 47% (n=287) had moderate periodontitis, 48% (n=296) had 
severe periodontitis (Page & Eke, 2007). The mean eGFR for the sample was 37 ml/min/1.73m2, 
mean age was 61 years; 62% were male, 67.6% were White, 50% never-smokers and 36% had 
diabetes. The mean PISA for this group was 483mm2 (Table 1).
Structural Equation Modelling
-Model investigating the effect of PISA on eGFR (Figure 1, Table 2)
The base model (model 1) with eGFR as the outcome and PISA as the exposure of interest showed 
no clinically or statistically significant direct effect of PISA on total serum FLC or CRP 
concentrations. There was a clinically and statistically significant direct effect of PISA on the 
latent variable oxidative stress with a 0.21 SD (95%CI: 0.06 to 0.36) change in the latent variable 
oxidative stress seen for every one SD increase in PISA. There was a clinically and statistically 
significant direct effect of total serum FLC concentration and the latent variable oxidative stress 
on eGFR with a 0.49 SD (95% CI:0.42 to 0.56) and a 0.33 SD (95%CI:0.20 to 0.45) change in 
eGFR seen with a one SD increase in serum FLC and the latent variable oxidative stress, 
respectively. There was no clinically or statistically significant direct effect of CRP on eGFR 
(Table 2). 
The next model (model 2) showed a clinically and statistically significant effect of BMI and 
HbA1C on CRP but not oxidative stress. The point estimates and confidence intervals from the 
previous model were stable to these changes (Table 2). 
The final model (model 3) showed no appreciable clinically or statistically significant effect of 
CRP on the latent variable oxidative stress. There was a clinically significant effect of the latent 
variable oxidative stress on CRP with a 1 SD increase in the latent variable oxidative stress 
leading to a 0.12 SD (95% CI:-0.02 to 0.21) change in CRP but this was not statistically 
significant. The point estimates and confidence intervals from the previous model were stable to 
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In investigating the indirect, path-specific effect of PISA on eGFR, there was no clinically or 
statistically significant effect of PISA on eGFR mediated via changes in serum FLC or CRP 
concentrations. There was a clinically and statistically significant indirect effect of PISA on eGFR, 
mediated via oxidative stress, such that a 10% increase in PISA led to a 3.0% decrease in eGFR 
(95% CI: 0.6-5.4) (Table 2). 
-Model investigating the effect of eGFR on PISA (Figure 2, Table 3)
The base model (model 1) with PISA as the outcome and eGFR as the exposure of interest showed 
that eGFR has a clinically and statistically significant direct effect on serum FLC, CRP 
concentration and the latent variables oxidative stress and blood biochemistry with a 0.54 SD 
(95%CI: 0.48 to 0.60), a 0.17 SD (95%CI: 0.09 to 0.25), a 0.40 SD (95%CI: 0.26 to 0.54) and a 
0.64 S.D (95%CI: 0.51 to 0.77) change seen respectively for every one SD decrease in eGFR. 
Serum FLC and CRP concentration and the latent variable blood biochemistry were not shown to 
have a clinically or statistically significant effect on PISA. The latent variable oxidative stress had 
a clinically significant direct effect on PISA but this was not statistically significant (Table 3). 
The next model (model 2) showed a clinically and statistically significant effect of BMI and 
HbA1C on CRP but not oxidative stress. The point estimates and confidence intervals from the 
previous model were stable to these changes (Table 3). 
The final model (model 3) showed a clinically and statistically significant effect of CRP on the 
latent variable oxidative stress and vice versa. The point estimates and confidence intervals from 
the previous model were stable to these changes (Table 3). 
In investigating the path-specific effect of eGFR on PISA, there was no clinically or statistically 
significant effect of eGFR on PISA via any pathway, apart from via the latent variable oxidative 
stress where a 10% decrease in eGFR led to a 25.0% increase in PISA (95%CI:0.4 to 49.6). 
Discussion
We found a bidirectional, causal relationship between periodontal inflammation and renal 
function: a 10% increase in PISA led to a 3.0% decrease in eGFR and a 10% decrease in eGFR led 
to a 25.0% increase in PISA. The 10% change in PISA in this cohort can be contextualised by 
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(349 mm2) and severe periodontitis (652 mm2) (Table 1). Based on the 4-variable, 5-year risk of 
kidney failure equation for non-American populations (Tangri et al., 2016), a 3% decrease in 
eGFR would, in this cohort, translate to a change in 5-year risk of kidney failure from 32% 
(S.D.29%) to 34% (S.D.30%). We also showed that oxidative stress provided the pathobiological 
basis for this bi-directional relationship, not the inflammatory load as measured by CRP and 
sFLCs, or altered blood biochemistry measured by calcium, phosphate and bicarbonate levels. 
This study is the largest of its kind with detailed periodontal phenotyping of patients with CKD at 
an elevated risk of CKD progression. Collection of detailed demographic and bio-clinical data 
allowed for adjustment for factors that might confound the relationship between periodontal 
inflammation, renal function and systemic inflammatory/oxidative stress markers. Oxidative stress 
was measured using assays validated in multicentre method validation studies (Augustyniak et al., 
2015; Breusing et al., 2010). The clinical and laboratory assessments allowed for comprehensive 
testing of causal assumptions using SEM. SEM facilitated the examination of many associations 
simultaneously and assumptions regarding the bidirectional effect of periodontal inflammation on 
renal function. The direct effects were standardized to allow comparison of the magnitude of 
various direct effects. These were interpreted as a percent change in the SD in the outcome for a 1 
SD change in the exposure. To aid clinical interpretation, the indirect effects were not standardized 
and were interpreted as a percent change in the outcome for a 10% change in the exposure.
We also used “latent variables” in addition to “observed variables” in SEM. Latent variables allow 
researchers to quantify unmeasured or unmeasurable confounders using data on observed variables 
associated with them. For example, “socio-economic status” (SES) is notoriously difficult to 
quantify. Using SEM, a latent variable for SES can be constructed based on observed variables 
such as employment status and highest educational attainment. SEM, therefore, has the potential to 
allow detailed assessment of the pathobiological relationship between periodontitis and CKD. 
Another strength of this study is the use of PISA to quantify periodontal inflammation. The use of 
case definitions of periodontitis, designed for epidemiological purposes, in investigating the 
association between periodontitis and systemic diseases, has previously been criticized (Grubbs et 
al., 2016; Ioannidou, Shaqman, Burleson, & Dongari-Bagtzoglou, 2010)  as it may not represent 
current periodontal health/inflammatory status. As a measure of periodontal inflammatory load, 
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of periodontal disease is important when unravelling the causal pathways between periodontal and 
systemic diseases.
This study builds on previous work evaluating the association between renal function and 
periodontal health (Ariyamuthu, Nolph, & Ringdahl, 2013; Chambrone et al., 2013; Deschamps-
Lenhardt et al., 2018; Zhao et al., 2018). Previous studies referred to a lack of evidence for a 
causal link between periodontitis and CKD (Nanayakkara & Zhou, 2019). A previous study using 
SEM on data from the National Health and Nutrition Examination Study (NHANES) III data 
demonstrated a bi-directional relationship between periodontitis and CKD (Fisher, Taylor, West, 
& McCarthy, 2011). We also reported a bidirectional relationship using more detailed periodontal 
and bio-clinical phenotyping of patients and more robust testing of the possible causal 
mechanisms. Another study used causal mediation analysis on data from the Electric Generation 
Authority of Thailand study to show a significant direct and indirect (via diabetes) effect of 
periodontitis on the incidence of CKD (Lertpimonchai et al., 2019). This study lacked data on 
inflammatory and oxidative stress markers and hence was unable to elucidate the mechanism of 
effect. Therefore, our study advances the understanding of how periodontal inflammation and 
renal function influence each other by demonstrating the mediating role of systemic oxidative 
stress. Our findings align with animal studies showing renal tissue damage linked to oxidative 
stress following periodontitis (Franca et al., 2017). 
Our study showed no major effect of periodontal inflammation on serum FLC concentration, 
contrary to a prior study (White et al., 2016). This may be due to differences periodontitis 
assessment or patient population; the previous study was conducted in participants with normal 
renal function and therefore normal renal clearance of FLCs. This may indicate that the increase in 
serum FLC concentration seen with decreased renal clearance of FLCs far out-weighs the 
contribution of periodontal inflammation to a rise in serum FLC concentration. Our study found 
no evidence of a significant effect of periodontal inflammation on systemic CRP levels 
contradicting previous reports and reviews (D'Aiuto et al., 2013; Demmer et al., 2013; Kumar et 
al., 2013). These discrepant findings may be due to the substantially higher levels of CRP in 
patients with CKD, consistent with other reports of high CRP levels in patients with CKD 
(Kalantar-Zadeh, 2007). Hence, our study maybe underpowered to detect the increases in CRP 
reported in other cohorts of patients with periodontitis (Demmer et al., 2013). Patients with CKD 
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et al., 2004). In patients with CKD, the less dramatic increase in markers of oxidative stress, 
compared with CRP, may make it possible for the effects of periodontal inflammation to be more 
readily detected in changes in oxidative stress levels than in changes in CRP levels. 
Our study also has limitations. Firstly, we are limited by the assumptions made in the causal 
diagrams describing the relationships between periodontal inflammation and renal function 
(Figures 1&2). The presence and absence of variables and arrows, along with the direction of 
arrows, are assumptions based on current thinking. The comprehensive causal diagrams do not 
capture the full complexity of the biological interactions. There may be an effect of renal function 
on periodontal inflammation, via the effect of renal function on immune function. In the absence 
of data quantifying immune function, this analysis was not possible. Furthermore, the cross-
sectional nature of this study does not allow for investigations of temporality which limits the 
understanding of the true causal nature of the observed relationships. Also, as with observational 
studies in general, unmeasured confounding, such as the effect of poor diet on both periodontal 
health and renal function, may explain the observed relationship. 
Additionally, analyses of isoprostanes and plasma carbonyls were only carried out on the first 586 
participants, resulting in missing data for the remainder of the cohort. This was mitigated by 
imputing the missing data using STATA’s maximum likelihood with missing values option in the 
SEMs. This adjusts the likelihood function, based on Markov chain Monte Carlo estimations, to 
allow every case to contribute information on the observed variables. In addition, sensitivity 
analyses conducted, limiting the data to those with known values of isoprostanes and plasma 
carbonyls, yielded similar results (data not shown). Finally, the particularly high CRP levels in this 
cohort, which may reflect the progressive nature of their CKD, may limit the generalizability of 
these results.
Our study highlights the role of periodontal inflammation as an occult source of increased 
systemic oxidative stress in CKD. Collecting data on oxidative stress in future studies may expand 
on these results. It is not known whether periodontitis treatment will improve the oxidative stress 
burden in patients with CKD and, ultimately, impact morbidity and mortality associated with 
CKD. Pilot studies are underway and these may provide the basis for randomized control trials to 
confirm whether the mechanistic link reported here is modifiable through periodontitis treatment 
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Tables
















Age (years) 61 (16) 0 50 (18) 59 (17) 64 (14)








































Diabetic (%) 36 0 30 30 42
HbA1C (mmols/mol) 49 (17.4) 4.7 46 (19.7) 47 (15.8) 51 (18.6)
BMI (kg/m2) 30 (7) 3.3 29 (6) 30 (7) 30 (7)
eGFR (ml/min/1.73m2) 37 (20) 1.95 47 (25) 38 (21) 35 (19)
uACR (mg/mmol) 100 (144) 10 151 (190) 87 (131) 108 (150)
Haemoglobin (g/dl) 12.4 (1.7) 1.8 12.7 (21) 12.3 (1.9) 12.5 (1.6)
Phosphate (mmol/L) 1.1 (0.2) 2.0 1.1 (0.2) 1.1 (0.2) 1.2 (0.2)
Calcium (mmol/L) 2.2 (0.1) 1.6 2.3 (0.1) 2.3 (0.1) 2.2 (0.1)
Bicarbonate (mEq/L) 24 (3.3) 2.4 24 (3.2) 24 (3.3) 24 (3.3)
Total cholesterol (mmol/L) 4.8 (1.4) 1.8 5.3 (1.8) 4.9 (1.3) 4.7 (1.4)
Hypertension (%) 94 0.5 93 94 94
PISA (mm2) 483 (532) 0.33 105 (114) 349 (360) 652 (632)
Mean PPD (mm) 2.7 (0.8) 0 1.8 (0.5) 2.5 (0.5) 3.4 (0.8)
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BOP (%) 33.8 (24.4) 0 12.8 (11.7) 26.8 (20.0) 42.6 (25.7)
CRP (mg/L) 7.4 (12.8) 0.8 6.0 (10.3) 7.5 (12.7) 7.5 (13.2)
Total serum FLC 
concentration 
108 (187) 0.8 74 (38) 109 (162) 112 (218)
Isoprostane (pg/ml) 26 (20) 26.8 22 (15) 26 (21) 26 (19)
Protein carbonyls (nmol/mg 
of protein)
1.2 (0.7) 25.9 1.1 (0.7) 1.1 (0.6) 1.2 (0.7)


































GCSE- General Certificate of Secondary Education (aged approximately 16); NVQ- National 
Vocal Qualification (aged approximately 16–18); GCE A-Level- General Certificate of Education 
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Table 2: Direct (standardized) and indirect (unstandardized) effects from PISA to eGFR
Model 1 Model 2 (model 1 + 






Model 3 (model 2 + 
feedback loop 
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BMI- body mass index; CRP- c-reactive protein; eGFR- estimated glomerular filtration rate; 
HbA1C- glycated haemoglobin A1C; OS- oxidative stress; PISA- periodontal inflamed surface 
area; sFLC- serum free light chain
NB: the latent variable OS (oxidative stress) is generated with lower values representing higher 
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Table 3: Direct (standardized) and indirect (unstandardized) effects from eGFR to PISA
Model 1 Model 2 (model 1 + 






Model 3 (model 2 + 
feedback loop 
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BB- Blood biochemistry; BMI- body mass index; CRP- c-reactive protein; eGFR- estimated 
glomerular filtration rate; HbA1C- glycated haemoglobin A1C; OS- oxidative stress; PISA- 
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Figure legends:
Figure 1: Causal diagram for the structural equation model with renal function, eGFR, as 
the outcome. 
Rectangles: Observed variables; Ovals: Latent variable; Green: Exposure and outcomes of 
interest; Purple: confounders; Orange: Mediators
*- paths included in Model 2, in addition to the base model. **- paths included in Model 3, in 
addition to Model 2.
BMI- body mass index; CRP- c-reactive protein; eGFR- estimated glomerular filtration rate; FLC- 
free light chain; HbA1C- glycated haemoglobin A1C; PISA- periodontal inflamed surface area; 
SES- socio-economic status
Figure 2: Causal diagram for the structural equation model with periodontal inflammation, 
PISA, as the outcome. 
Rectangles: Observed variables; Ovals: Latent variable; Green: Exposure and outcomes of 
interest; Purple: confounders; Orange: Mediators
*- paths included in Model 2, in addition to the base model. **- paths included in Model 3, in 
addition to Model 2.
BMI- body mass index; CRP- c-reactive protein; eGFR- estimated glomerular filtration rate; FLC- 
free light chain; HbA1C- glycated haemoglobin A1C; PISA- periodontal inflamed surface area; 
SES- socio-economic status
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